Additionally, CCA-derived CAFs induced CCA cell viability and resistance to gemcitabine by activation of pSTAT3 and the proteins involved in cell viability, as well as inducing IL-6 secretion in CCA cells. The gene discussed is IL6; the disease is cholangiocarcinoma.